-
Lipidated Nanophotosensitizer Disables Tumor EVs
2026-09-11
Miao and colleagues developed a palmitic-acid-displayed nanophotosensitizer that accumulates in tumor cells and tumor extracellular vesicles (TEVs), enabling synchronized photodynamic damage to both compartments. The study provides a selective strategy for suppressing primary tumor growth while disrupting TEV-mediated communication that supports metastasis, although its clinical and mechanistic transferability remains to be established.
-
Caspofungin Workflows for Candida Research
2026-09-11
Caspofungin provides a practical benchmark for fungal cell wall biosynthesis inhibition, from Candida susceptibility testing to delayed-treatment models of invasive candidiasis. This guide translates its β-1,3-glucan synthase activity into reproducible assay design, comparative studies, and troubleshooting decisions.
-
Ibrexafungerp Against Resistant Candida auris
2026-09-10
Wiederhold and colleagues combined broth microdilution testing with a delayed-treatment neutropenic mouse model to examine ibrexafungerp against fluconazole-resistant Candida auris. The study found consistent in vitro activity and improved survival and renal fungal clearance with ibrexafungerp, supporting further evaluation of orally active glucan-synthesis inhibitors for difficult Candida infections.
-
Exo1: Precision Control of Exocytic Pathways
2026-09-10
Exo1 offers translational researchers a mechanistically distinct way to interrogate ER-to-Golgi traffic, ARF1 behavior, and exocytic control. This article connects its use as a cellular perturbation tool with emerging tumor extracellular vesicle research while clearly separating experimentally supported findings from future hypotheses.
-
KU-55933: ATM Kinase Inhibitor Workflow
2026-09-09
Build reproducible ATM-inhibition assays with KU-55933 by combining phospho-Akt, cell-cycle, viability, and metabolic readouts. This guide translates disease-modeling lessons from patient-specific iPSC research into practical control design without overstating what the reference study demonstrated.
-
Direct Mouse Genotyping Kit Plus Workflow Guide
2026-09-09
The Direct Mouse Genotyping Kit Plus supports rapid, purification-free DNA preparation for routine mouse genotyping, transgene confirmation, and colony decisions. Its PCR master mix with dye reagents also simplifies endpoint analysis, while disciplined controls help distinguish genotype calls from downstream macrophage phenotypes.
-
Lactate Workflows for Metabolic–Immune Assays
2026-09-08
Use L-lactate as both a quantitative readout of glycolytic activity and a controlled perturbation for hypoxia, mitochondrial, tumor, and immune experiments. This workflow translates the NAT1–ENO1–lactate–PD-L1 mechanism into practical sampling, dosing, normalization, and troubleshooting decisions.
-
Exo1 for Causal Membrane-Trafficking Assays
2026-09-08
Exo1, or methyl 2-(4-fluorobenzamido)benzoate, enables acute interrogation of Golgi–ER traffic and exocytosis. This article develops a paper-informed assay strategy for separating trafficking effects from tumor extracellular vesicle function without overstating preclinical evidence.
-
Direct Mouse Genotyping Kit Plus: From Genotype to Biology
2026-09-07
The Direct Mouse Genotyping Kit Plus supports rapid, purification-free PCR while helping researchers connect allele verification with lineage-tracing and macrophage biology. This article explains how the K1027 workflow can strengthen transgene studies, knockout models, and interpretation of tissue-resident immune-cell plasticity.
-
G-Quadruplexes Modulate TDP-43 Toxicity in ALS Models
2026-09-07
Oldani et al. show that G-quadruplexes directly influence TDP-43 aggregation, intracellular distribution, and toxicity across biochemical, yeast, HEK293T, and motor-neuron-like NSC-34 models. The study positions RNA G-quadruplex modulation as a mechanistic avenue for investigating ALS-associated protein misfolding, while also defining important limits for translating G-quadruplex ligands across DNA and RNA systems.
-
Dynasore in Endocytosis: From Blockade to Proof
2026-09-05
Dynasore is a cell-permeable dynamin GTPase inhibitor for dissecting membrane fission, vesicle trafficking, and viral entry. This evidence-focused guide explains how to use Dynasore as a causal assay tool while avoiding overinterpretation of clathrin-dependent endocytosis results.
-
Direct Mouse Genotyping Kit Plus for Colony Studies
2026-09-04
The Direct Mouse Genotyping Kit Plus simplifies tissue-to-PCR workflows for colony screening, transgene detection, and knockout validation without DNA precipitation or column purification. Its dye-containing high-fidelity master mix also supports a fast transition from amplification to gel-based genotype calls.
-
Cisapride (R 51619) in Cardiotoxicity Workflows
2026-09-04
Cisapride combines 5-HT4 receptor agonism with hERG potassium channel inhibition, making it a useful reference probe for linking pathway activation to electrical and structural cardiac phenotypes. This practical guide shows how to deploy it in iPSC-cardiomyocyte imaging, electrophysiology, and early cardiac arrhythmia research while controlling solvent, exposure, and interpretation risks.
-
Pazopanib Hydrochloride Assay Workflows
2026-09-03
Build more informative Pazopanib Hydrochloride experiments by separating growth inhibition from true cell killing and pairing dose–response curves with time-resolved endpoints. This workflow supports anti-angiogenic agent studies, renal cell carcinoma research, and soft tissue sarcoma models while highlighting practical troubleshooting steps.
-
AL-8810: Prostaglandin F2α Antagonist
2026-09-03
AL-8810 is a prostaglandin F2α antagonist that selectively targets the FP receptor for cellular and tissue research. Product benchmarks and a peer-reviewed mouse menstrual-like model support its use for dissecting FP receptor signaling, vascular responses, smooth muscle biology, and MMP-2 secretion inhibition.